Tri-Sprintec 28 Day Shortage Update: What Patients Need to Know in 2026

If you've been searching "Tri-Sprintec shortage 2026" because your pharmacy said it's out of stock, here is the clearest, most up-to-date answer available.

Is Tri-Sprintec 28 Day in a Shortage in 2026?

No — as of 2026, Tri-Sprintec 28 Day (norgestimate/ethinyl estradiol triphasic tablets) is NOT listed on the FDA's current drug shortage database. The national supply of this medication is generally adequate, with six or more manufacturers producing AB-rated generic versions.

However, this doesn't mean every patient can easily fill their prescription. Individual pharmacies can and do experience temporary stockouts due to factors that have nothing to do with a national shortage. Understanding those factors is key to finding your medication.

Background: The Ortho Tri-Cyclen Discontinuation

Much of the confusion around Tri-Sprintec availability traces back to the discontinuation of Ortho Tri-Cyclen, the original brand-name version of norgestimate/ethinyl estradiol triphasic. Janssen Pharmaceuticals discontinued Ortho Tri-Cyclen after generic versions took over the market. Tri-Sprintec was among the first generics to emerge, and it has been widely available for years.

Some patients who grew up taking Ortho Tri-Cyclen still ask for it by that name. When pharmacies report not having "Ortho Tri-Cyclen," patients sometimes interpret this as a shortage — when in reality, the brand simply no longer exists and the generic is widely available.

What Is Causing Tri-Sprintec Supply Gaps in 2026?

Even without a formal shortage, these real-world factors can cause supply gaps at specific pharmacies:

Increased demand for oral contraceptives. Following ongoing policy changes around reproductive healthcare, prescriptions for oral contraceptives have increased in many states. Some local pharmacies haven't adjusted their ordering levels to meet this new demand.

Distributor allocation fluctuations. Pharmacies order medications through drug wholesalers (McKesson, AmerisourceBergen, Cardinal Health), whose allocation schedules can shift without notice. A pharmacy may simply miss their usual shipment window.

Manufacturer-specific production timing. Each manufacturer runs its own production schedules. If your pharmacy primarily stocks Tri-Sprintec from one manufacturer and that manufacturer is between production runs, the pharmacy may be temporarily out even though other manufacturers' equivalent products are available elsewhere.

Insurance formulary specificity. Your insurance plan may only cover one specific generic version. If that version is what your pharmacy is out of, you may face a coverage issue even when other equivalent generics are in stock at the same pharmacy.

What Should Patients Do Right Now?

Here are the most effective steps to take if your pharmacy is out of Tri-Sprintec 28 Day:

Ask for an equivalent generic. Tri-Estarylla, Tri-Linyah, Tri-Mili, Tri-Nymyo, and Tri-VyLibra are all therapeutically identical. Your pharmacist may have one of these in stock.

Don't just call one pharmacy. Stock varies widely by location. A pharmacy 2 miles away may have plenty in stock.

Use medfinder to search multiple pharmacies at once without spending hours on the phone.

Contact your prescriber. If you're close to running out of active pills, call your provider. Don't stop taking active hormone pills without guidance.

Consider mail-order for future fills. Large mail-order pharmacies maintain higher inventory levels and can ship a 90-day supply, reducing monthly availability uncertainty.

How to Monitor Tri-Sprintec Availability Going Forward

You can check the FDA's drug shortage database directly at accessdata.fda.gov. For real-time pharmacy-level availability, medfinder can help you quickly find a pharmacy near you that has your medication in stock. For step-by-step search strategies, see our guide: how to find Tri-Sprintec 28 Day in stock near you.